Endometriosis and Microvascular Dysfunction: Role of Inflammation

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Endometriosis

Interventions

DRUG

Salsalate Pill

Salsalate acts as an NFkB inhibitor to reduce systemic inflammation

DRUG

Placebo

Placebo for the salsalate intervention

Trial Locations (1)

RECRUITING

The Pennsylvania State University, University Park

All Listed Sponsors

lead

Penn State University

OTHER